Literature DB >> 9425023

Energetics of polar side-chain interactions in helical peptides: salt effects on ion pairs and hydrogen bonds.

J S Smith1, J M Scholtz.   

Abstract

The energetics of the interaction between the polar side chains of glutamate or aspartate with lysine and glutamate with histidine have been determined using a model alanine-based peptide helix. An evaluation of the effects of NaCl and pH on the interactions between these acidic and basic residues in several different orientations and spacings in an alpha-helical peptide has been made. For many of the peptides, we find a considerable interaction between the polar side chains. In general, the shorter side chains show stronger interactions, but there are more restrictions on the precise geometry of the interactions as dictated by the spacing and orientation of the polar residues in the alpha-helical peptide. The energetics of the interaction between the fully-charged ion pairs can be diminished by added salt, but the interaction is not completely screened even at 2.5 M NaCl. The strength of the interaction between a charged and neutral side chain is not as sensitive to the ionic strength of the solution, suggesting that solvent-exposed hydrogen bonds are forming. All the interactions between the polar residues employed here stabilize helix formation, suggesting that solvent-exposed ion pairs and hydrogen bonds can contribute to the conformational stability of proteins and peptides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425023     DOI: 10.1021/bi972026h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Energetic and entropic contributions to the interactions between like-charged groups in cationic peptides: A molecular dynamics simulation study.

Authors:  Marcos Villarreal; Guillermo Montich
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

2.  Circular dichroism and ultraviolet resonance Raman indicate little Arg-Glu side chain α-helix peptide stabilization.

Authors:  Zhenmin Hong; Zeeshan Ahmed; Sanford A Asher
Journal:  J Phys Chem B       Date:  2011-03-22       Impact factor: 2.991

3.  Salt bridges: geometrically specific, designable interactions.

Authors:  Jason E Donald; Daniel W Kulp; William F DeGrado
Journal:  Proteins       Date:  2011-01-05

4.  Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37.

Authors:  Adam A Strömstedt; Mukesh Pasupuleti; Artur Schmidtchen; Martin Malmsten
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

5.  Dynamics of alpha helix formation in the CSAW model.

Authors:  J Lei; K Huang
Journal:  Eur Phys J E Soft Matter       Date:  2008-09-30       Impact factor: 1.890

6.  Addition of side-chain interactions to 3(10)-helix/coil and alpha-helix/3(10)-helix/coil theory.

Authors:  J K Sun; A J Doig
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

7.  Fluorescence resonance energy transfer analysis of merlin conformational changes.

Authors:  Robert F Hennigan; Lauren A Foster; Mary F Chaiken; Timmy Mani; Michelle M Gomes; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

8.  Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin.

Authors:  M O Steinmetz; W Jahnke; H Towbin; C García-Echeverría; H Voshol; D Müller; J van Oostrum
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

9.  Surface salt bridges stabilize the GCN4 leucine zipper.

Authors:  E J Spek; A H Bui; M Lu; N R Kallenbach
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

10.  Identification of a unique "stability control region" that controls protein stability of tropomyosin: A two-stranded alpha-helical coiled-coil.

Authors:  Robert S Hodges; Janine Mills; Susanna McReynolds; J Paul Kirwan; Brian Tripet; David Osguthorpe
Journal:  J Mol Biol       Date:  2009-07-21       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.